Cargando…
Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia
Peroxisome proliferator-activated receptor alpha (PPARA) has been suggested as a therapeutic target for chronic lymphocytic leukemia (CLL). However, the underlying molecular mechanism remains largely unclear. In this study, we analyzed DNA next-generation sequencing (NGS) data and clinical informati...
Autores principales: | Xiang, Xixi, Li, Fu, Zhou, Sha, Zeng, Yunjing, Deng, Xiaojuan, Zhang, Hongyang, Li, Jiali, Liu, Hongyun, Rao, Jun, Gao, Lei, Zhang, Cheng, Wen, Qin, Gao, Li, Zhang, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317583/ https://www.ncbi.nlm.nih.gov/pubmed/37404899 http://dx.doi.org/10.1155/2023/8456833 |
Ejemplares similares
-
PB1954: PROGNOSTIC ANALYSIS OF GENE MUTATIONS ON TIME-TO-FIRST TREATMEN IN 93 NEWLY DIAGNOSED CHRONIC LYMPHOBLASTIC LEUKEMIA PATIENTS
por: Xiang, Xixi, et al.
Publicado: (2023) -
PB2094: APPLICATION OF WHOLE-GENOME SEQUENCING FOR COPY NUMBER ABNORMALITY IN MULTIPLE MYELOMA
por: LI, Jiali, et al.
Publicado: (2023) -
MicroRNA-141 Represses HBV Replication by Targeting PPARA
por: Hu, Wei, et al.
Publicado: (2012) -
Correction: MicroRNA-141 Represses HBV Replication by Targeting PPARA
por: Hu, Wei, et al.
Publicado: (2012) -
Association of EPAS1 and PPARA Gene Polymorphisms with High-Altitude Headache in Chinese Han Population
por: Shen, Yang, et al.
Publicado: (2020)